Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors

Andrea Savarino, Roberto Cauda, Antonio Cassone

Risultato della ricerca: Contributo in rivistaArticolo in rivista

18 Citazioni (Scopus)


We read with great interest the brief report by Skinner-Adams et al. [1] with regard to the capacity of some HIV-1 protease inhibitors (PIs) to inhibit the growth of Plasmodium falciparum in vitro at clinically achievable and relevant concentrations. Their results are particularly interesting to us, because we have recently obtained strong evidence that the PIs saquinavir, ritonavir, and indinavir, besides exerting antiplasmodial activity in vitro, are also active in a murine model of malaria (A. Savarino, A. Sannella, R. Spaccapelo, M. Dell'Agli, T. Dottorini, G. Galli, C. Severini, E. Bosisio, J. R. Boelaert, A. Crisanti, G. Majori, A. Cassone, and R. Cauda, unpublished data). Nonetheless, we are rather surprised by the statement made by Skinner-Adams et al. that a database search of the P. falciparum genome did not lead to the identification of any plasmodial homologue of the HIV-1 protease.
Lingua originaleEnglish
pagine (da-a)1381-1382
Numero di pagine2
RivistaJ Infect Dis.
Stato di pubblicazionePubblicato - 2005


  • Aspartic proteases
  • Plasmodium falciparum


Entra nei temi di ricerca di 'Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors'. Insieme formano una fingerprint unica.

Cita questo